Drug Database · Clinicians

Betamethasone + Gentamicin

Brands (3) Diprogenta, Betagen, Betave GShow all

Anti-inflammatory/ anti-pruritic/ antibacterial; Anti-inflammatory/Anti-pruritic/Anti-bacterial; and others PH FDA category
Fixed-dose combination.

Rx · Prescription drug6 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. US FDA label

  • Use: INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Sulfate in 0.9% Sodium Chloride Injection and other antibacterial drugs, Gentamicin Sulfate in 0.9%… US FDA label

    Kidney dosing: Gentamicin (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Normal kidney function: 3 mg/kg/day in 3 doses every 8 hours; up to 5 mg/kg/day for life-threatening infection, reduced as soon as possible. Obese patients: dose by lean body mass. Measure peaks (4 to 6 mcg/mL) and troughs (label). Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels.
    CrCl 30–59 mL/min
    After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4 examples: CrCl about 40–45 (SCr 2–2.2): 50%; 30–35 (SCr 2.6–3): 35% of the usual dose every 8 hours. Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
    CrCl 15–29 mL/min
    After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4 example: CrCl about 20–25: 25%; 15–20: 20% of the usual dose every 8 hours. Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
    CrCl <15 mL/min (not on dialysis)
    After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4: CrCl about 10–15: 15%; under 10: 10% of the usual dose every 8 hours. Specialist input. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
    Hemodialysis (intermittent)
    1 to 1.7 mg/kg at the end of each dialysis, depending on severity of infection; an 8-hour hemodialysis lowers levels by about 50% (label). Check levels.
    Peritoneal dialysis
    No PD dose in label; removal by peritoneal dialysis is much slower than by hemodialysis. For PD-associated peritonitis (ISPD 2022): 0.6 mg/kg intraperitoneally once daily, intermittent (in one exchange daily with a dwell of at least 6 hours); continuous dosing is not advised. Check levels; specialist input.
    CRRT
    No data in label, and gentamicin is not in the Li 2020 CRRT table. Level-guided dosing with specialist input.
    • Dialyzable? Yes by hemodialysis (about 50% over 8 hours; label); much less by peritoneal dialysis. Protein binding 0% to 30%.
    • Monitoring Peak and trough levels; serum creatinine before and during therapy; urinalysis; hearing and vestibular function; magnesium, calcium and potassium (wasting, Fanconi-like syndrome reported). Avoid other nephrotoxic drugs and potent diuretics.

    From the Gentamicin monograph (renalcarematters.com, reviewed).

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per gram cream: 500 mcg/1 mg
  • Per gram topical cream: 1 mg/1 mg, 500 mcg/1 mg
  • Per gram ointment: 500 mcg/1 mg
  • Topical cream: 1 mg/500 mcg

Registered products in the Philippines

6 products registered with the Food and Drug Administration (FDA) Philippines list Betamethasone + Gentamicin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products6
Philippine FDA-registered products for Betamethasone + Gentamicin
Package insert
BetagenBetamethasone (dipropionate) + Gentamicin
500mcg/1 mg per gram CreamLaminated plastic tube x 5 g, 10 g, 15 g, 20 g and 30 g (Box of 1's)
Rx
Azine Healthcare Pvt. Ltd.India
Ollen Pharma Trading Inc.
DRP-17440
Dec 16, 2030
Betave GBetamethasone (as Dipropionate) + Gentamicin (as Sulfate)
500 mcg/1 mg per gram (0.05%/0.1% w/w) Topical CreamPlastic Laminated Tube x 5 g, 10 g and 20 g (Box of 1’s)
Rx
Yash PharmaceuticalsIndia
VE Pharma Inc.Trader: Vexxa Lifesciences Pvt. Ltd.
DR-XY49285
Dec 10, 2029
DiprogentaBetamethasone (as dipropionate)/Gentamicin (as sulfate)
500 mcg/1 mg per gram CreamAluminum Tube x 5 g and 3 g (Physician's Sample) (Box of 1's)
Rx
PT Organon Pharma Indonesia TbkIndonesia
Importer: Organon (Philippines) Incorporated
DRP-6238
Sep 8, 2029
DIPROGENTABetamethasone + Gentamicin
500mcg / 1mg per gram OintmentAluminum tube x 5g and 10g Box of 1 's
Rx
PT. Organon Pharma Indonesia Tbk.Indonesia
Importer: Organon (Philippines) Incorporated
DRP-6239
Feb 16, 2029
NoneBetamethasone (as Valerate) + Gentamicin (as Sulfate)
1 mg/1 mg per gram (0.1%/0.1% w/w) Topical CreamAluminum Collapsible Tube x 10 g
Rx
MCB Dermatological ProductsPhilippines
—
DR-XY45761
Jan 26, 2027
(no brand name)Gentamicin sulfate + Betamethasone (as dipropionate)
1 mg/500 mcg Topical CreamAluminum Tube x 15 g (Box of 1's)
Rx
Y.S.P. Industries (M)Sdn. BhdMalaysia
Yung Shin (Philippines), Inc.
DRP-11692
Apr 25, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .